Stem cell transplantation has demonstrated a crucial role in pancreatic repair and the restoration of its functional capacity. Research has shown that mesenchymal stem cells (MSCs) contribute to pancreatic regeneration by promoting cell survival, reducing inflammation, and enhancing insulin secretion.

The positive metabolic effects of MSC transplantation in the treatment of diabetes have been well-documented in scientific literature. These cells aid in regulating blood glucose levels by improving insulin sensitivity and supporting pancreatic islet cell function. Furthermore, their immunomodulatory properties help protect insulin-producing beta cells from autoimmune destruction, particularly in type 1 diabetes.

Mesenchymal stem cells serve as an ideal starting material for transplantation due to their ability to expand into large quantities while maintaining their regenerative potential. With their capacity to differentiate into insulin-producing cells and support pancreatic function, MSCs offer a promising therapeutic approach for diabetic patients, paving the way for innovative treatments that go beyond conventional diabetes management.